These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11092546)

  • 81. Thermochemistry of the interaction between peptides and vancomycin or ristocetin.
    Rodríguez-Tebar A; Vázquez D; Pérez Velázquez JL; Laynez J; Wadsö I
    J Antibiot (Tokyo); 1986 Nov; 39(11):1578-83. PubMed ID: 3793627
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The natural design of vancomycin family antibiotics to bind their target peptides.
    Waltho JP; Williams DH
    Ciba Found Symp; 1991; 158():73-86; discussion 87-91, 92-7. PubMed ID: 1935428
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
    Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T
    Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.
    Reynolds PE; Depardieu F; Dutka-Malen S; Arthur M; Courvalin P
    Mol Microbiol; 1994 Sep; 13(6):1065-70. PubMed ID: 7854121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Molecular recognition by secondary metabolites.
    Williams DH; Stone MJ; Mortishire-Smith RJ; Hauck PR
    Biochem Pharmacol; 1990 Jul; 40(1):27-34. PubMed ID: 2372307
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Vancomycin: ligand recognition, dimerization and super-complex formation.
    Jia Z; O'Mara ML; Zuegg J; Cooper MA; Mark AE
    FEBS J; 2013 Mar; 280(5):1294-307. PubMed ID: 23298227
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
    Fesik SW; Armitage IM; Ellestad GA; McGahren WJ
    Mol Pharmacol; 1984 Mar; 25(2):281-6. PubMed ID: 6700574
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
    Lee JG; Sagui C; Roland C
    J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Selectivity for D-lactate incorporation into the peptidoglycan precursors of Lactobacillus plantarum: role of Aad, a VanX-like D-alanyl-D-alanine dipeptidase.
    Deghorain M; Goffin P; Fontaine L; Mainardi JL; Daniel R; Errington J; Hallet B; Hols P
    J Bacteriol; 2007 Jun; 189(11):4332-7. PubMed ID: 17400741
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures.
    Wang F; Zhou H; Olademehin OP; Kim SJ; Tao P
    ACS Omega; 2018 Jan; 3(1):37-45. PubMed ID: 29399648
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Different modes of vancomycin and D-alanyl-D-alanine peptidase binding to cell wall peptide and a possible role for the vancomycin resistance protein.
    Knox JR; Pratt RF
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1342-7. PubMed ID: 2386365
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies.
    Izsépi L; Erdei R; Tevyashova AN; Grammatikova NE; Shchekotikhin AE; Herczegh P; Batta G
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33499349
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Molecular Dynamics Simulation of Atomic Interactions in the Vancomycin Binding Site.
    Olademehin OP; Kim SJ; Shuford KL
    ACS Omega; 2021 Jan; 6(1):775-785. PubMed ID: 33458529
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Magnetic microsphere-based methods to study the interaction of teicoplanin with peptides and bacteria.
    Piyasena ME; Real LJ; Diamond RA; Xu HH; Gomez FA
    Anal Bioanal Chem; 2008 Nov; 392(5):877-86. PubMed ID: 18712518
    [TBL] [Abstract][Full Text] [Related]  

  • 96. N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
    Wu ZC; Isley NA; Boger DL
    ACS Infect Dis; 2018 Oct; 4(10):1468-1474. PubMed ID: 30067012
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Single-molecule force spectroscopy and imaging of the vancomycin/D-Ala-D-Ala interaction.
    Gilbert Y; Deghorain M; Wang L; Xu B; Pollheimer PD; Gruber HJ; Errington J; Hallet B; Haulot X; Verbelen C; Hols P; Dufrêne YF
    Nano Lett; 2007 Mar; 7(3):796-801. PubMed ID: 17316058
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hexapeptide derivatives of glycopeptide antibiotics: tools for mechanism of action studies.
    Allen NE; LeTourneau DL; Hobbs JN; Thompson RC
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2344-8. PubMed ID: 12121903
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Structure of ristocetin A in complex with a bacterial cell-wall mimetic.
    Nahoum V; Spector S; Loll PJ
    Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):832-8. PubMed ID: 19622867
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Vancomycin resistance: modeling backbone variants with D-Ala-D-Ala and D-Ala-D-Lac peptides.
    Leung SS; Tirado-Rives J; Jorgensen WL
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1236-9. PubMed ID: 19128968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.